Signs of Cross‐Reactivity Between SARS ‐ CoV ‐2 and Other Coronaviruses in a Pre‐Vaccine Swedish School Setting
Acta Paediatrica · 2026
DOI: 10.1111/apa.70532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Lina Schollin Ask und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Vaccination Programmes, Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Coronavirus. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Government.
Abstract (Originalsprache)
Aim
This pilot study explored signs of immunological cross‐reactivity between SARS‐CoV‐2 and human coronaviruses (HCoVs) in a Swedish school setting.
Methods
A cross‐sectional, hypothesis‐generating study was conducted late 2020 before vaccines against COVID‐19 were available. Forty‐seven 7–8‐year‐old children, seventy‐five 14‐year‐old adolescents, fifty‐four 17‐year‐old adolescents, and 52 adult school staff were included, and immune responses to SARS‐CoV‐2 and HCoVs were assessed.
Results
The SARS‐CoV‐2 seroprevalence was high in the older age groups (33%–41%). Seropositive individuals had significantly higher levels of antibodies against betacorona virus compared to seronegative individuals. SARS‐CoV‐2 seropositivity was rare among the 7–8‐year‐old children despite the high endemic context. SARS‐CoV‐2‐specific T‐cell responses in the absence of SARS‐CoV‐2‐specific antibodies were seen in all age groups.
Conclusion
The data support a role for cross‐reactive immune responses induced by recent HCoV infections, with cross‐reactive T‐cell responses providing protection against COVID‐19 in young children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit for Vaccination Programmes, Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden.
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
- Sachs' Children and Youth Hospital, Stockholm, Sweden.
- Unit for Analysis, Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden.
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
- Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
ORCID-Profile: Lina Schollin Ask, Olof Hertting
Förderung
- Swedish Government
Zitieren
APA
Ask, L. S., Berenzon, S. K., Marking, U., Nouiser, S., Bråve, A., Andersson, S., Nordenhäll, C., Alfvén, T., Tecleab, T., Hertting, O., Sandberg, T., Christ, W., Klingström, J., Blom, K., & Nilsson, C. (2026). Signs of Cross‐Reactivity Between SARS ‐ CoV ‐2 and Other Coronaviruses in a Pre‐Vaccine Swedish School Setting. Acta Paediatrica. https://doi.org/10.1111/apa.70532
Vancouver
Ask LS, Berenzon SK, Marking U, Nouiser S, Bråve A, Andersson S, et al. Signs of Cross‐Reactivity Between SARS ‐ CoV ‐2 and Other Coronaviruses in a Pre‐Vaccine Swedish School Setting. Acta Paediatrica. 2026. doi:10.1111/apa.70532
BibTeX
@article{Ask2026,
author = {Ask, Lina Schollin and Berenzon, Sharon Kühlmann and Marking, Ulrika and Nouiser, Sara and Bråve, Andreas and Andersson, Sören and Nordenhäll, Charlotta and Alfvén, Tobias and Tecleab, Teghesti and Hertting, Olof and Sandberg, Tyler and Christ, Wanda and Klingström, Jonas and Blom, Kim and Nilsson, Charlotta},
title = {Signs of Cross‐Reactivity Between SARS ‐ CoV ‐2 and Other Coronaviruses in a Pre‐Vaccine Swedish School Setting},
journal = {Acta Paediatrica},
year = {2026},
doi = {10.1111/apa.70532}
}
EUVIMED